Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

No standard exists for the treatment of myelodysplastic syndrome relapsing after allogeneic stem cell transplantation. We performed a retrospective registry analysis of outcomes and risk factors in 698 patients, treated with different strategies. The median overall survival from relapse was 4.7 mont...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Haematologica
Glavni autori: Schmid, Christoph, de Wreede, Liesbeth C., van Biezen, Anja, Finke, Jürgen, Ehninger, Gerhard, Ganser, Arnold, Volin, Liisa, Niederwieser, Dietger, Beelen, Dietrich, Alessandrino, Paolo, Kanz, Lothar, Schleuning, Michael, Passweg, Jakob, Veelken, Hendrik, Maertens, Johan, Cornelissen, Jan J., Blaise, Didier, Gramatzki, Martin, Milpied, Noel, Yakoub-Agha, Ibrahim, Mufti, Ghulam, Rovira, Montserrat, Arnold, Renate, de Witte, Theo, Robin, Marie, Kröger, Nikolaus
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792268/
https://ncbi.nlm.nih.gov/pubmed/29101205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.168716
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items